Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

AstraZeneca Will Rise Again
Seeking Alpha
Wednesday, October 3, 2012 - 10:44am
tags:
AstraZeneca
Lundbeck, Takeda seek U.S. approval for antidepressant
Chicago Tribune, IL
Tuesday, October 2, 2012 - 12:17pm
tags:
Takeda, Lundbeck, antidepressants, vortioxetine
Abbott CEO: Gonzalez Resume Was An Error
Pharmalot
Tuesday, October 2, 2012 - 12:16pm
tags:
Richard Gonzalez, Abbott Labs, AbbVie
POZEN patents upheld in Treximet patent litigation appeal
The Fly on the Wall
Tuesday, October 2, 2012 - 12:13pm
tags:
Pozen, patents, Treximet, generics
Lessons From Biotech's Best Third Quarter Stocks
TheStreet.com
Tuesday, October 2, 2012 - 11:59am
tags:
Celsion, XenoPort, Peregrine Pharmaceuticals, Sunesis, Opexa, StemCells, Catalyst Pharmaceutical Partners, Hemispherx, Sarepta, Savient
Roche declines comment on report of Illumina bid, Bloomberg reports
Yahoo/Fly on the Wall
Tuesday, October 2, 2012 - 11:57am
tags:
Roche, Illumina, M&A
Illumina Rises On Unusually High Volume
TheStreet.com
Tuesday, October 2, 2012 - 11:56am
tags:
Illumina
Questcor: What's Really Changed?
Seeking Alpha
Tuesday, October 2, 2012 - 11:55am
tags:
Questcor, earnings
ArQule stock plunges as lung cancer study shelved
Yahoo/AP
Tuesday, October 2, 2012 - 11:25am
tags:
Arqule, lung cancer, Daiichi Sankyo, tivantinib, non-small cell lung cancer
3 Giant Leaps for MannKind
Motley Fool
Tuesday, October 2, 2012 - 10:47am
tags:
MannKind, Afrezza
Pfizer, Novartis And Northwest Biotherapeutics In A Race For IVF Inspired Cancer Cure
Seeking Alpha
Tuesday, October 2, 2012 - 10:45am
tags:
Pfizer, Novartis, Northwest Biotherapeutics, In Vitro Fertilization, cancer
Healthcare Business Review: GenVec’s Conference Success, Neurocrine Begins Trials
Wall St. Cheat Sheet
Tuesday, October 2, 2012 - 10:30am
tags:
GenVec, Neurocrine, NBI-98854
J&J Experimental Diabetes Drug Helps High-Risk Patients
Bloomberg
Tuesday, October 2, 2012 - 10:05am
tags:
diabetes, JNJ, canagliflozin, Dapagliflozin, Bristol-Myers Squibb, AstraZeneca
Ablynx enters alliance with Merck worth up to 448 million euros
Reuters
Tuesday, October 2, 2012 - 9:54am
tags:
Ablynx, Merck
[video]Can Pharmacyclics Turn It Around?
Motley Fool
Tuesday, October 2, 2012 - 9:50am
tags:
Pharmacyclics
AstraZeneca Suspends The Buyback: Let The M&A Speculation Commence
Seekin Alpha
Monday, October 1, 2012 - 9:52pm
tags:
M&A, AstraZeneca, Seattle Genetics, Regeneron, ONYX Pharmaceuticals, Biomarin, Forest Labs
Can Hemispherx Find Success In The Chronic Fatigue Market?
Seeking Alpha
Monday, October 1, 2012 - 9:49pm
tags:
chronic fatigue syndrome, Hemispherx, Ampligen
Cleveland BioLabs hepatocellular carcinoma drug granted orphan status by FDA
Yahoo/Fly the on Wall
Monday, October 1, 2012 - 9:46pm
tags:
orphan drugs, hepatocellular carcinoma, Cleveland BioLabs, Quinacrine
[video]Pfizer's Life After Lipitor: A 20% Rally Perhaps?
Bloomberg
Monday, October 1, 2012 - 9:44pm
tags:
Pfizer, patents, Lipitor, dividends
Merck’s HPV Vaccine Gardasil Shown Safe in Kaiser Study
Bloomberg
Monday, October 1, 2012 - 9:40pm
tags:
Merck, HPV, vaccines, Gardasil

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.